LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Thermo Fisher and Bio-Techne Enter Into Strategic Distribution Agreement for Europe

By LabMedica International staff writers
Posted on 01 May 2024
Print article
Image: Thermo Fisher will distribute Bio-Techne products across Europe (Photo courtesy of 123RF)
Image: Thermo Fisher will distribute Bio-Techne products across Europe (Photo courtesy of 123RF)

Thermo Fisher Scientific (Waltham, MA USA) has entered into a strategic distribution agreement with Bio-Techne Corporation (Minneapolis, MN, USA), resulting in a significant collaboration between two industry leaders in scientific research, diagnostics, and biotechnology. As per the agreement, Thermo Fisher will distribute Bio-Techne's wide range of products, including antibodies, proteins, immunoassay kits, reagents, and enzymes to laboratories and research institutions across Europe through the European arm of its Fisher Scientific Channel.

Bio-Techne's products are designed to speed up research and enhance outcomes in areas such as cell and gene therapy, immunology, neuroscience, and others. Following this collaboration, Thermo Fisher has reinforced its commitment to providing access to its clients with the most advanced technologies and expertise, eventually resulting in advancements in scientific knowledge and improvement in human health. The distribution agreement highlights Thermo Fisher's dedication to encouraging innovation and collaboration among members of the scientific community. By entering into strategic partnerships with leading companies such as Bio-Techne, Thermo Fisher maintains its position as a trusted partner for researchers and laboratories across Europe.

"We are thrilled to forge this partnership with Bio-Techne, a company renowned for its pioneering advancements in the life sciences industry," said Claire Wallace, President Research and Safety Market, Europe at Thermo Fisher. "By adding Bio-Techne's high-quality products to our comprehensive portfolio, we aim to further empower scientists and researchers with the tools they need to drive breakthrough discoveries and advancements in healthcare."

"We are excited to partner with Thermo Fisher to expand the reach of our products and services throughout Europe," said Kim Kelderman, Bio-Techne's President and Chief Executive Officer. "By leveraging the Fisher Scientific Channel's extensive European distribution network and industry expertise, we aim to enhance support for researchers and accelerate scientific discoveries that address some of the most pressing challenges in healthcare today."

Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Respiratory QC Panel
Assayed Respiratory Control Panel
New
Centrifuge
Hematocrit Centrifuge 7511M4

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Sekisui Diagnostics UK Ltd.